As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/19/24  Ligand Pharmaceuticals Inc.       8-K:5,9     4/17/24   11:343K                                                            
10/30/20  Ligand Pharmaceuticals Inc.       8-K:5,9    10/26/20   13:370K                                                            
 9/10/15  Ligand Pharmaceuticals Inc.       8-K:5,9      9/9/15    2:125K                                                            
 4/12/13  Ligand Pharmaceuticals Inc.       8-K:5,9     4/12/13    2:116K                                                            
11/19/10  Ligand Pharmaceuticals Inc.       8-K:5,7,9  11/19/10    3:49K                                    Donnelley … Solutions/FA 
 12/6/07  Ligand Pharmaceuticals Inc.       8-K:5,9     12/6/07    3:15K                                                             
11/14/05  Ligand Pharmaceuticals Inc.       8-K:5,9     11/8/05    2:7K                                                              

____________
¹	Filing/Form Type:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.